Anebulo Pharmaceuticals, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Anebulo Pharmaceuticals, Inc. (ANEB) is 4.42M

According to Anebulo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.42M. This represents a change of -90.92% compared to the average of 48.68M of the last 4 quarters.

Anebulo Pharmaceuticals, Inc. (ANEB) Historical Enterprise Value (quarterly & annually)

How has ANEB Enterprise Value performed in the past?

The mean historical Enterprise Value of Anebulo Pharmaceuticals, Inc. over the last ten years is 93.75M. The current 4.42M Enterprise Value has changed 371.19% with respect to the historical average. Over the past ten years (40 quarters), ANEB's Enterprise Value was at its highest in in the September 2020 quarter at 168.21M. The Enterprise Value was at its lowest in in the March 2025 quarter at 22.36M.

Anebulo Pharmaceuticals, Inc. (ANEB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anebulo Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anebulo Pharmaceuticals, Inc. (ANEB) Average Enterprise Value

How has ANEB Enterprise Value performed in the past?

The current Enterprise Value of Anebulo Pharmaceuticals, Inc. (ANEB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Anebulo Pharmaceuticals, Inc. (ANEB) Enterprise Value vs. Peers

How is ANEB’s Enterprise Value compared to its peers?

Anebulo Pharmaceuticals, Inc.’s Enterprise Value is greater than Tiziana Life Sciences Ltd (-65269000.00), less than Immix Biopharma, Inc. (366.25M), less than Whitehawk Therapeutics Inc (146.21M), less than Zentalis Pharmaceuticals, Inc. (339.16M), less than Coya Therapeutics, Inc. (19.74M), less than Pliant Therapeutics, Inc. (71.61M), less than Clene Inc. (64.76M), less than MacroGenics, Inc. (203.27M), less than Estrella Immunopharma, Inc. (31.60M), less than OKYO Pharma Limited (48.33M),

Build a custom stock screener for Anebulo Pharmaceuticals, Inc. (ANEB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anebulo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anebulo Pharmaceuticals, Inc. (ANEB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anebulo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.